soul trial oral semaglutide cardiovascular outcomes 2024 nejm results and in... : New England Journal of Medicine Long-term kidney outcomes of semaglutide – Oral Semaglutide Cuts Cardiovascular Risk

Breastfeeding considerations are complex, as there is insufficient data regarding the presence of these medications in human milk or their effects on the breastfed infant

Dont Overdo Cardio Cardiovascular exercise is great for heart health, but excessive cardioespecially in a calorie deficitcan accelerate muscle loss

If you find that appetite suppression alone does not change your eating behaviors, that is equally valuable information that can guide future treatment decisions

Weight gain often becomes more noticeable during this time, particularly as fat distribution shifts more toward the abdomen, even if overall weight doesnt drastically change. But maintaining a healthy weight during menopause isnt just for your physical appearance